The pharmaceutical industry has long relied on data-driven decision-making to advance drug discovery, improve clinical trials ...

A tool-based approach can significantly aid in the harmonization of regulatory requirements, mitigate inadvertent risks, and ...

The Pakistan Single Window (PSW) and the Drug Regulatory Authority of Pakistan (DRAP) has officially launched a Digital ...

In 2014, the share of OAI status globally stood at 6 per cent which has now more than doubled standing at 14 per cent ...

India’s pharmaceutical industry has witnessed a sharp drop of 11 per cent in regulatory violation instances in 2024, ...

The global structured product label management market has been segmented into solution, end-user, and region. Based on solution type, the market is bifurcated into software and services. Software is ...

The 10th edition of the GCC Regulatory Affairs Pharma Summit, held at the prestigious Mövenpick Grand Al Bustan in Dubai, ...

Pakistan Single Window (PSW) and the Drug Regulatory Authority of Pakistan (DRAP) officially launched the DRAP Clearance ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

India’s pharmaceutical sector has reported an 11 per cent decline in regulatory violations in 2024, marking a significant improvement in compliance with global standards, according to a recent ...

The pharmaceutical industry is among the most heavily ... how pharmaceutical companies are using NLP to improve regulatory compliance activities. Data-driven risk management: The biopharma product ...

Gain insights into the U.S. market, valued at $363.4 Million in 2024, and China, forecasted to grow at an impressive 4.8% ...